KRAS and non-small cell lung carcinoma: Mutations in Kirsten rat sarcoma viral oncogene homolog (KRAS) represent the most frequent oncogene alterations in NSCLC, with variable incidences across ethnicities, being less prevalently in East Asian (5–11%) and Latin American countries (14%) than in Caucasian patients (25–40%) [2, 3].